Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
242.88
+9.40 (4.03%)
Oct 20, 2026, 10:26 AM EDT - Market open
Biogen Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 35,886 | 25,818 | 22,283 | 37,495 | 39,877 | 35,242 | |
Market Cap Growth | 71.17% | 15.86% | -40.57% | -5.97% | 13.15% | -6.47% |
Enterprise Value | 42,957 | 28,448 | 27,235 | 42,918 | 40,731 | 39,390 |
Last Close Price | 233.48 | 175.99 | 152.92 | 258.77 | 276.92 | 239.92 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 43.01 | 19.97 | 13.65 | 32.29 | 13.09 | 22.65 |
Forward PE | 18.64 | 13.66 | 9.71 | 17.54 | 17.70 | 13.94 |
PS Ratio | 3.44 | 2.61 | 2.30 | 3.81 | 3.92 | 3.21 |
PB Ratio | 1.83 | 1.41 | 1.33 | 2.53 | 2.98 | 3.22 |
P/TBV Ratio | - | 9.98 | 40.82 | 172.63 | 6.88 | 12.10 |
P/FCF Ratio | 12.79 | 12.59 | 8.19 | 29.52 | 34.86 | 10.42 |
P/OCF Ratio | 11.98 | 11.71 | 7.75 | 24.23 | 28.81 | 9.68 |
PEG Ratio | 1.21 | 4.75 | 1.90 | 4.38 | 17.68 | 39.30 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.15 | 2.88 | 2.82 | 4.36 | 4.00 | 3.59 |
EV/EBITDA Ratio | 12.37 | 7.84 | 8.29 | 17.93 | 11.52 | 10.04 |
EV/EBIT Ratio | 16.52 | 9.99 | 10.42 | 22.60 | 13.49 | 11.47 |
EV/FCF Ratio | 15.41 | 13.87 | 10.01 | 33.79 | 35.60 | 11.65 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.44 | 0.37 | 0.40 | 0.50 | 0.50 | 0.70 |
Debt / EBITDA Ratio | 2.40 | 1.78 | 1.97 | 2.93 | 1.85 | 1.91 |
Debt / FCF Ratio | 3.10 | 3.25 | 2.47 | 5.85 | 5.87 | 2.28 |
Net Debt / Equity Ratio | 0.38 | 0.13 | 0.26 | 0.43 | 0.08 | 0.27 |
Net Debt / EBITDA Ratio | 2.11 | 0.66 | 1.32 | 2.67 | 0.32 | 0.76 |
Net Debt / FCF Ratio | 2.62 | 1.18 | 1.60 | 5.02 | 0.97 | 0.89 |
Asset Turnover | 0.33 | 0.34 | 0.35 | 0.38 | 0.42 | 0.45 |
Inventory Turnover | 0.93 | 0.90 | 0.85 | 1.31 | 1.69 | 1.74 |
Quick Ratio | 0.94 | 1.70 | 0.77 | 1.04 | 2.39 | 1.34 |
Current Ratio | 1.87 | 2.68 | 1.35 | 2.00 | 2.99 | 1.83 |
Return on Equity (ROE) | 4.58% | 7.39% | 10.36% | 8.24% | 24.33% | 15.96% |
Return on Assets (ROA) | 5.21% | 6.19% | 5.95% | 4.62% | 7.79% | 8.86% |
Return on Invested Capital (ROIC) | 8.86% | 11.22% | 10.60% | 9.35% | 16.55% | 21.63% |
Return on Capital Employed (ROCE) | 8.90% | 10.90% | 11.60% | 8.10% | 14.20% | 17.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.42% | 5.01% | 7.32% | 3.10% | 7.64% | 4.42% |
FCF Yield | 7.82% | 7.94% | 12.21% | 3.39% | 2.87% | 9.60% |
Buyback Yield / Dilution | -1.20% | -0.82% | -0.21% | 0.27% | 2.41% | 7.25% |